ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,348, issued on April 21, was assigned to Catalent Ontario Ltd. (Windsor, Canada).
"Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof" was invented by John Lopez (Windsor, Canada), Peter Draper (Amherstburg, Canada), Sankalp Vashishtha (Mississauga, Canada), Nancy Klassen (Windsor, Canada) and Christina Armstrong (Windsor, Canada).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of using a naproxen fill formulation suitable for encapsulation into a soft gel dosage unit to treat inflammation and pain. Methods include administering naproxen to a subject in need thereof to treat pain and infl...